The presence of TAMs has been shown to correlate with poor prognosis in TNBC, as they can facilitate tumor growth and metastasis while also contributing to immune evasion by endocytosing anti-PD-L1 antibodies, thereby neutralizing the therapeutic effects of ICIs [145, 146]. The gene discussed is CD274; the disease is neoplasm.